Home » Topics » Disease categories and therapies » Ocular

Ocular
RSS

New muscarinic compounds from Alcon especially useful for Rx of glaucoma

July 29, 1999

New agents for glaucoma disclosed by Alcon in recent patent literature

July 27, 1999

Sunrise LTK System not recommended for FDA approval

July 26, 1999

Alcon's new prostaglandin analogues for glaucoma

July 26, 1999

FDA Advisory Committee votes against recommending Allergan therapy for dry eye disease

July 26, 1999

FDA approves same-day, second-eye treatment with Sunrise LTK system

July 15, 1999

More on PEDF: protein also has ophthalmic indications

July 13, 1999

CAT gets U.K. approval to begin phase II trials of novel glaucoma treatment

July 12, 1999

Allergan ciclosporin NDA up for review this month by advisory committee

July 12, 1999

Midostaurin is a promising new agent for preventing vision loss

July 9, 1999

Popular Stories

Today's news in brief
BioWorld
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
New mechanism of action identified for QC-6352
BioWorld Science
QC-6352 is a small molecule developed to inhibit the histone demethylase 4 (KDM4) that has shown potent antitumoral activity and which has a derivative named...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...